<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01686308</url>
  </required_header>
  <id_info>
    <org_study_id>CIRCAT</org_study_id>
    <nct_id>NCT01686308</nct_id>
  </id_info>
  <brief_title>The Effect of Cataract on Photoentrainment of the Circadian Rhythm in Humans</brief_title>
  <acronym>CIRCAT</acronym>
  <official_title>The Effect of Cataract on Photoentrainment of the Circadian Rhythm in Humans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Glostrup University Hospital, Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Glostrup University Hospital, Copenhagen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cataract is globally the most common cause of blindness and in Denmark the operation with -&#xD;
      50.000 treatments per year - is the most common eye operation. The cause of cataract is&#xD;
      growth and denaturation of the lens proteins. This leads to an increased absorption of blue&#xD;
      light and increased light scatter. This may affect newly discovered cells in the retina that&#xD;
      are involved in the regulation of the circadian rhythm. When the internal circadian rhythm is&#xD;
      not synchronized with the external day and night a phase-shift occurs. Most people know of&#xD;
      this discomfort as jet-lag, but the consequences may be much more severe such as heighten&#xD;
      risk of cancer and cardiovascular disease.&#xD;
&#xD;
      The goal of this project is to study how the circadian regulating cells of the retina is&#xD;
      affected by cataract and by the operation. Cataract patients are studied before and after the&#xD;
      operation with questionnaires, hormone and activity measurements and with a specialized pupil&#xD;
      measurement that measures the indirect response of the circadian regulating cells to blue&#xD;
      light.&#xD;
&#xD;
      Results from this study aim to shed light on the regulatory mechanisms of the eye on the&#xD;
      circadian rhythm and how these are affected by cataract. Furthermore, choice of intraocular&#xD;
      lens is evaluated. This may have impact on clinical practise especially with regard to choice&#xD;
      of intraocular lens and widened indications for cataract surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2011</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pupillary response to blue light</measure>
    <time_frame>1 year/1month</time_frame>
    <description>Measurement of the consensual light response to red (630 nm) and blue (470 nm)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Questionnaire</measure>
    <time_frame>1year/1month</time_frame>
    <description>Pittsburgh Sleep Quality Index and the Morningness Eveningness Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire</measure>
    <time_frame>1 year/1 month</time_frame>
    <description>Morningness-eveningness questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Melatonin day variety analysis</measure>
    <time_frame>1year/1month</time_frame>
    <description>Salivary samples collected with 4 hour interval during 24 hours. Analyzed for melatonin concentration with Radio Immuno Assay (RIA).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Actigraphy</measure>
    <time_frame>1year/1month</time_frame>
    <description>Activity measured during 7 days and 7 nights with the Spectrum Actiwatch, Respironics, Philips</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">76</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>Conventional Intra Ocular Lens (IOL)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard minimal incision cataract surgery by phacoemulsification and posterior intraocular lens implantation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Yellow Intra Ocular Lens (IOL)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standard minimal incision cataract surgery by phacoemulsification and posterior intraocular lens implantation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Yellow Intra Ocular Lens (IOL)</intervention_name>
    <description>Standard operation with blue light filter Yellow IOL implantation</description>
    <arm_group_label>Yellow Intra Ocular Lens (IOL)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Conventional Intra Ocular Lens (IOL)</intervention_name>
    <description>Standard operation with conventional IOL implantation</description>
    <arm_group_label>Conventional Intra Ocular Lens (IOL)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age related/senile bilateral cataract&#xD;
&#xD;
          -  Eligible for phaco-emulsification on both eyes&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Known eye disease other than cataract.&#xD;
&#xD;
          -  Known systemic disease, which may affect the retina (untreated hypertension, DM etc.)&#xD;
&#xD;
          -  Known systemic disease, which may affect the lens.&#xD;
&#xD;
          -  Known psychiatric disease.&#xD;
&#xD;
          -  Known sleep or circadian rhythm disorder, not caused by lowered blue light&#xD;
             transmission by the lens.&#xD;
&#xD;
          -  Per- and post operative complications&#xD;
&#xD;
          -  Use of drugs that may affect the sleep.&#xD;
&#xD;
        For a subpopulation also:&#xD;
&#xD;
          -  Poor cooperation.&#xD;
&#xD;
          -  Severe refraction abnormalities.&#xD;
&#xD;
          -  Previous eye surgery&#xD;
&#xD;
          -  Nystagmus&#xD;
&#xD;
          -  Congenital or acquired abnormalities of: eye lids and eye area, cornea or iris.&#xD;
&#xD;
          -  Use of medicine that may affect the pupillary response.&#xD;
&#xD;
          -  Use of drugs that may affect the pupillary response.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adam E Brøndsted, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Glostrup UH</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Glostrup University Hospital</name>
      <address>
        <city>Glostrup</city>
        <zip>DK-2600</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>February 2015</verification_date>
  <study_first_submitted>November 30, 2011</study_first_submitted>
  <study_first_submitted_qc>September 17, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 18, 2012</study_first_posted>
  <last_update_submitted>February 9, 2015</last_update_submitted>
  <last_update_submitted_qc>February 9, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 10, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Glostrup University Hospital, Copenhagen</investigator_affiliation>
    <investigator_full_name>Adam Elias Brøndsted</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>cataract</keyword>
  <keyword>circadian rhythm</keyword>
  <keyword>pupillometry</keyword>
  <keyword>blue light transmission</keyword>
  <keyword>questionnaire</keyword>
  <keyword>sleep</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

